More than 41,000 bottles of a brand of nasal spray were recalled nationwide as the Food and Drug Administration (FDA) upgraded the recall classification last week.
The reason for the recall was given as "microbial contamination of a non-sterile product," and the microorganism was found to be Pseudomonas lactis, a type of bacteria. Philadelphia-based Medical Products Laboratories initiated the recall.
It's not clear whether there were any reported illnesses or adverse health issues in connection with the product recall. The Epoch Times contacted Walgreens for comment.
A Walgreens spokesperson told media outlets this week: “Under the guidance of the FDA, our supplier has initiated a voluntary recall of Walgreens Saline Nasal Spray WITH XYLITOL. This was done out of an abundance of caution and the safety of our customers remains our top priority. Consumers with affected product should not use it and return it to a store for a full refund.”
The recalled products include the lot number of 71409 and an expiration date of Feb. 28, 2027; and a lot number of 71861 and an expiration date of Aug. 31, 2027, according to the FDA. The recall, which impacts products sold nationwide, has a number of D-0179-2026, the FDA notice said.
"Seasonal influenza activity remains low nationally but is increasing," the agency said, adding that COVID-19 levels are currently "very low" and are decreasing. RSV levels are considered low but increasing, the agency said.